FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to a method of treating the patients with idiopathic neutrophil lobular panniculitis, characterized by the fact that on the background of the basic therapy diprospan is administered along the edge and in the center of compaction in a single dose of 0.15–7 mg per 1 cm2 with the interval between the first two injections of 5 days, the third introduction is performed 7 days after the second injection.
EFFECT: present invention provides maximum improvement of functional status and locomotor function of patient's locomotor apparatus, that is manifested in regress of rashes, process stabilization, persistent clinical improvement, increased motor activity of joints.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING LOBULAR PANNICULITIS - LIPODERMATOSCLEROSIS PATIENTS | 2019 |
|
RU2701392C1 |
| METHOD FOR EXPRESS ASSESSMENT OF X-RAY STAGE OF ACUTE SARCOIDOSIS ASSOCIATED WITH SEPTAL PANNICULITIS | 2021 |
|
RU2758811C1 |
| METHOD OF SKIN SARCOIDOSIS TREATMENT | 2010 |
|
RU2442588C2 |
| DIAGNOSTIC METHOD OF ATYPICAL CASES OF FAMILIAL MEDITERRANEAN FEVER | 2020 |
|
RU2739411C1 |
| METHOD FOR TREATING THE SYSTEMIC FORM OF ADULT STILL'S DISEASE USING COLCHICINE | 2021 |
|
RU2774778C1 |
| METHOD FOR DETERMINING INDICATIONS TO BEGINNING OF RECEPTION OF GENETIC ENGINEERING BIOLOGICAL PREPARATIONS WITH INEFFECTIVENESS OF BASIC ANTI-INFLAMMATORY PREPARATIONS IN EARLY FORMS OF PSORIATIC ARTHRITIS | 2020 |
|
RU2731807C1 |
| METHOD FOR ASSESSING THE RISK OF JOINT EROSIONS IN PATIENTS WITH PSORIATIC ARTHRITIS | 2022 |
|
RU2791661C1 |
| METHOD OF INJECTION THERAPY OF PAIN SYNDROME IN SPINE OSTEOCHONDROSIS | 2009 |
|
RU2421247C2 |
| METHOD OF TREATING IDIOPATIC DERMATOMYOSITIS | 0 |
|
SU1009468A1 |
| METHOD OF TREATING PEMPHIGUS VULGARIS | 2012 |
|
RU2530625C2 |
